CN109134387A - A kind of preparation method of Sulfamonomethoxime Sodium and Sulfamonomethoxime Sodium prepared by this method - Google Patents

A kind of preparation method of Sulfamonomethoxime Sodium and Sulfamonomethoxime Sodium prepared by this method Download PDF

Info

Publication number
CN109134387A
CN109134387A CN201710464902.4A CN201710464902A CN109134387A CN 109134387 A CN109134387 A CN 109134387A CN 201710464902 A CN201710464902 A CN 201710464902A CN 109134387 A CN109134387 A CN 109134387A
Authority
CN
China
Prior art keywords
preparation
sodium
sulfamonomethoxime
sulfamonomethoxime sodium
daimeton
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710464902.4A
Other languages
Chinese (zh)
Inventor
马沛燃
李建正
李星
万毅
李贵欣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henan Hou Yi Pharmaceutical Co Ltd
Original Assignee
Henan Hou Yi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan Hou Yi Pharmaceutical Co Ltd filed Critical Henan Hou Yi Pharmaceutical Co Ltd
Priority to CN201710464902.4A priority Critical patent/CN109134387A/en
Publication of CN109134387A publication Critical patent/CN109134387A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69Benzenesulfonamido-pyrimidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a kind of preparation method of Sulfamonomethoxime Sodium, and the preparation method of Sulfamonomethoxime Sodium provided by the present invention, production process alkali wasteliquid is few, and waste liquid is almost neutrality, high income, product purity height.Sulfamonomethoxime Sodium made from this method is easily separated with solvent, and product purity is high, high income, is suitable for industrialized production.

Description

Between a kind of preparation method and sulfanilamide (SN) prepared by this method of Sulfamonomethoxime Sodium Sulfamonomethoxine sodium
Technical field
The present invention relates to the preparation method of veterinary drug technology of preparing more particularly to a kind of Sulfamonomethoxime Sodium and thus side The Sulfamonomethoxime Sodium of method preparation.
Background technique
Sulfamonomethoxime Sodium is the strongest sulfa drug of antibertisis in vivo and in vitro, to most of gram-positive bacterias and yin Property bacterium have compared with high inhibition act on, bacterium to this medicine generate drug resistance it is slower.It is mainly used for sensitive bacteria, toxoplasm, eperytozoa Various diseases and its mixed infection caused by body.
Preparing Sulfamonomethoxime Sodium common method at present is that oxygen pyrimidine is reacted with sodium hydroxide solution between sulfanilamide (SN), instead It answers liquid to be decolourized, filters, dry obtained Sulfamonomethoxime Sodium.The alkali wasteliquid amount that this method generates is big, and yield is low, product Impurity content is high.
Summary of the invention
To solve the above problems, the present invention provides a kind of preparation method of Sulfamonomethoxime Sodium, preparation process alkali is useless Liquid is few, high income, and product purity is high.
The technical solution of the present invention is as follows: a kind of preparation method of Sulfamonomethoxime Sodium and sulfanilamide (SN) prepared by this method Between Sulfamonomethoxine sodium, comprising the following steps:
(1) daimeton, sodium hydroxide are added in organic solvent, under the conditions of 54 ~ 98 DEG C of temperature, are stirred to react 0.5-2 hours, obtain solution A;
(2) active carbon is added to solution A, stirring decoloration 0.3-0.8 hours filters while hot, obtains filtrate;
(3) filtrate first naturally cools to 20 ~ 30 DEG C, then at 0 ~ 5 DEG C, keeps the temperature 1-3 hours, and filtering obtains filter residue;
(4) wash filter residue with a small amount of dehydrated alcohol, 55 ~ 60 DEG C vacuum drying 2-4 hours, obtain Sulfamonomethoxime Sodium.
In the step (1), the mass ratio of daimeton and sodium hydroxide is 1:(0.13 ~ 0.15).
In the step (1), the mass ratio of daimeton and sodium hydroxide is 1:0.14.
In the step (1), the mass volume ratio of daimeton and organic solvent is 1:(8.5 ~ 15), unit is g/ml。
In the step (1), the mass volume ratio of daimeton and organic solvent is 1:10, unit g/ml.
In the step (1), used organic solvent is ethyl alcohol.
In the step (2), the volume mass ratio of active carbon and organic solution is 0.3:100, unit g/ml.
The Sulfamonomethoxime Sodium of the preparation method preparation of above-mentioned Sulfamonomethoxime Sodium.
Beneficial effects of the present invention: the preparation method of Sulfamonomethoxime Sodium provided by the present invention, production process alkali Waste liquid is few, and waste liquid is almost neutrality, high income, product purity height.Sulfamonomethoxime Sodium made from this method is easily and solvent Separation, product purity is high, high income, is suitable for industrialized production.
Specific embodiment
Embodiment 1
A kind of preparation method of Sulfamonomethoxime Sodium, comprising the following steps:
(1) daimeton, sodium hydroxide are added in organic solvent, under the conditions of 54 ~ 98 DEG C of temperature, are stirred to react 0.5-2 hours, obtain solution A;
(2) active carbon is added to solution A, stirring decoloration 0.3-0.8 hours filters while hot, obtains filtrate;
(3) filtrate first naturally cools to 20 ~ 30 DEG C, then at 0 ~ 5 DEG C, keeps the temperature 1-3 hours, and filtering obtains filter residue;
(4) wash filter residue with a small amount of dehydrated alcohol, 55 ~ 60 DEG C vacuum drying 2-4 hours, obtain Sulfamonomethoxime Sodium.
Embodiment 2
A kind of preparation method of Sulfamonomethoxime Sodium, comprising the following steps:
(1) daimeton, sodium hydroxide are added in organic solvent, under the conditions of 54 ~ 98 DEG C of temperature, are stirred to react 1 Hour, obtain solution A;
(2) active carbon is added to solution A, stirring decoloration 0.5 hour filters while hot, obtains filtrate;
(3) filtrate first naturally cools to 20 ~ 30 DEG C, then at 0 ~ 5 DEG C, keeps the temperature 2 hours, and filtering obtains filter residue;
(4) filter residue is washed with a small amount of dehydrated alcohol, is dried in vacuo 3 hours at 55 ~ 60 DEG C, obtains Sulfamonomethoxime Sodium.
Embodiment 3
A kind of preparation method of Sulfamonomethoxime Sodium, comprising the following steps:
By 20g daimeton, 2.8g sodium hydroxide is added in 200ml ethyl alcohol, under the conditions of 70 ~ 82 DEG C of temperature, stirring 0.6g active carbon is added in reaction 1 hour, and stirring decoloration 0.5 hour is filtered while hot, and filtrate first naturally cools to 20 ~ 30 DEG C, then At 0 ~ 5 DEG C, keep the temperature 2 hours, filtering, washed with a small amount of dehydrated alcohol it is colourless to cleaning solution, it is 3 small in 55 ~ 60 DEG C of vacuum drying When, obtain Sulfamonomethoxime Sodium 20.92g, yield 96.97%.Sulfamonomethoxime Sodium is white crystalline powder, pure Degree is 99.4%.Waste liquid weakly acidic pH is filtered during the preparation process.
Embodiment 4
A kind of preparation method of Sulfamonomethoxime Sodium, comprising the following steps:
By 20g daimeton, 2.8g sodium hydroxide is added in 200ml methanol, under the conditions of 60 ~ 68 DEG C of temperature, stirring 0.6g active carbon is added in reaction 1 hour, and stirring decoloration 0.5 hour is filtered while hot, and filtrate first naturally cools to 20 ~ 30 DEG C, then At 0 ~ 5 DEG C, keep the temperature 2 hours, filtering, washed with a small amount of dehydrated alcohol it is colourless to cleaning solution, it is 3 small in 55 ~ 60 DEG C of vacuum drying When, obtain Sulfamonomethoxime Sodium 19.84g, yield 91.98%.Sulfamonomethoxime Sodium is white crystalline powder, pure Degree is 99.1%.Waste liquid weakly acidic pH is filtered during the preparation process.
Embodiment 5
A kind of preparation method of Sulfamonomethoxime Sodium, comprising the following steps:
By 20g daimeton, 2.8g sodium hydroxide is added in 200ml normal propyl alcohol, under the conditions of 95 ~ 98 DEG C of temperature, stirs Reaction 1 hour to be mixed, 0.6g active carbon is added, stirring decoloration 0.5 hour is filtered while hot, and filtrate first naturally cools to 20 ~ 30 DEG C, Again at 0 ~ 5 DEG C, keep the temperature 2 hours, filtering, washed with a small amount of dehydrated alcohol it is colourless to cleaning solution, 55 ~ 60 DEG C be dried in vacuo 3 Hour, obtain Sulfamonomethoxime Sodium 20.22g, yield 93.74%.Sulfamonomethoxime Sodium is white crystalline powder, Purity is 99.2%.Waste liquid weakly acidic pH is filtered during the preparation process.
Embodiment 6
A kind of preparation method of Sulfamonomethoxime Sodium, comprising the following steps:
By 20g daimeton, 2.8g sodium hydroxide is added in 200ml acetone, under the conditions of 53 ~ 58 DEG C of temperature, stirring 0.6g active carbon is added in reaction 1 hour, and stirring decoloration 0.5 hour is filtered while hot, and filtrate first naturally cools to 20 ~ 30 DEG C, then At 0 ~ 5 DEG C, keep the temperature 2 hours, filtering, washed with a small amount of dehydrated alcohol it is colourless to cleaning solution, it is 3 small in 55 ~ 60 DEG C of vacuum drying When, obtain Sulfamonomethoxime Sodium 19.92g, yield 92.35%.Sulfamonomethoxime Sodium is white crystalline powder, pure Degree is 99.5%.Waste liquid weakly acidic pH is filtered during the preparation process.
Embodiment 7
A kind of preparation method of Sulfamonomethoxime Sodium, comprising the following steps:
By 20g daimeton, 2.6g sodium hydroxide is added in 170ml ethyl alcohol, under the conditions of 70 ~ 82 DEG C of temperature, stirring 0.51g active carbon is added in reaction 2 hours, and stirring decoloration 0.6 hour is filtered while hot, and filtrate first naturally cools to 20 ~ 30 DEG C, then At 0 ~ 5 DEG C, keep the temperature 2.5 hours, filtering, washed with a small amount of dehydrated alcohol it is colourless to cleaning solution, 55 ~ 60 DEG C be dried in vacuo 3.5 hours, obtain Sulfamonomethoxime Sodium 20.42g, yield 94.67%.Sulfamonomethoxime Sodium is white crystalline powder End, purity 99.4%.Waste liquid weakly acidic pH is filtered during the preparation process.
Embodiment 8
A kind of preparation method of Sulfamonomethoxime Sodium, comprising the following steps:
By 20g daimeton, 3.0g sodium hydroxide is added in 300ml ethyl alcohol, under the conditions of 70 ~ 82 DEG C of temperature, stirring 0.9g active carbon is added in reaction 1.5 hours, and stirring decoloration 0.5 hour is filtered while hot, and filtrate first naturally cools to 20 ~ 30 DEG C, Again at 0 ~ 5 DEG C, keep the temperature 1.5 hours, filtering, washed with a small amount of dehydrated alcohol it is colourless to cleaning solution, 55 ~ 60 DEG C be dried in vacuo 2 hours, obtain Sulfamonomethoxime Sodium 20.75g, yield 96.20%.Sulfamonomethoxime Sodium is white crystalline powder, Purity is 99.3%.Waste liquid weakly acidic pH is filtered during the preparation process.
Embodiment 9
A kind of preparation method of Sulfamonomethoxime Sodium, comprising the following steps:
By 20g daimeton, 3.0g sodium hydroxide is added in 250ml ethyl alcohol, under the conditions of 70 ~ 82 DEG C of temperature, stirring 0.75g active carbon is added in reaction 0.5 hour, and stirring decoloration 0.8 hour is filtered while hot, and filtrate first naturally cools to 20 ~ 30 DEG C, Again at 0 ~ 5 DEG C, keep the temperature 1 hour, filtering, washed with a small amount of dehydrated alcohol it is colourless to cleaning solution, 55 ~ 60 DEG C be dried in vacuo 4 Hour, obtain Sulfamonomethoxime Sodium 20.70g, yield 95.97%.Sulfamonomethoxime Sodium is white crystalline powder, Purity is 99.3%.Waste liquid weakly acidic pH is filtered during the preparation process.
Embodiment 10
A kind of preparation method of Sulfamonomethoxime Sodium, comprising the following steps:
By 20g daimeton, 2.8g sodium hydroxide is added in 250ml ethyl alcohol, under the conditions of 70 ~ 82 DEG C of temperature, stirring 0.75g active carbon is added in reaction 1.5 hours, and stirring decoloration 0.3 hour is filtered while hot, and filtrate first naturally cools to 20 ~ 30 DEG C, Again at 0 ~ 5 DEG C, keep the temperature 3 hours, filtering, washed with a small amount of dehydrated alcohol it is colourless to cleaning solution, 55 ~ 60 DEG C be dried in vacuo 3 Hour, obtain Sulfamonomethoxime Sodium 20.90g, yield 96.89%.Sulfamonomethoxime Sodium is white crystalline powder, Purity is 99.3%.Waste liquid weakly acidic pH is filtered during the preparation process.
What has been described above is only a preferred embodiment of the present invention, it is noted that for those skilled in the art, Without depart from that overall concept of the invention, several changes and improvements can also be made, these also should be considered as of the invention Protection scope.

Claims (8)

1. a kind of preparation method of Sulfamonomethoxime Sodium, it is characterised in that: the following steps are included:
(1) daimeton, sodium hydroxide are added in organic solvent, under the conditions of 54 ~ 98 DEG C of temperature, are stirred to react 0.5-2 hours, obtain solution A;
(2) active carbon is added to solution A, stirring decoloration 0.3-0.8 hours filters while hot, obtains filtrate;
(3) filtrate first naturally cools to 20 ~ 30 DEG C, then at 0 ~ 5 DEG C, keeps the temperature 1-3 hours, and filtering obtains filter residue;
(4) wash filter residue with a small amount of dehydrated alcohol, 55 ~ 60 DEG C vacuum drying 2-4 hours, obtain Sulfamonomethoxime Sodium.
2. the preparation method of Sulfamonomethoxime Sodium according to claim 1, it is characterised in that: in the step (1), The mass ratio of daimeton and sodium hydroxide is 1:(0.13 ~ 0.15).
3. the preparation method of Sulfamonomethoxime Sodium according to claim 2, it is characterised in that: in the step (1), The mass ratio of daimeton and sodium hydroxide is 1:0.14.
4. the preparation method of Sulfamonomethoxime Sodium according to claim 1, it is characterised in that: in the step (1), The mass volume ratio of daimeton and organic solvent is 1:(8.5 ~ 15), unit g/ml.
5. the preparation method of Sulfamonomethoxime Sodium according to claim 4, it is characterised in that: in the step (1), The mass volume ratio of daimeton and organic solvent is 1:10, unit g/ml.
6. the preparation method of Sulfamonomethoxime Sodium according to claim 1, it is characterised in that: in the step (1), Used organic solvent is ethyl alcohol.
7. the preparation method of Sulfamonomethoxime Sodium according to claim 1, it is characterised in that: in the step (2), Active carbon and the volume mass of organic solution ratio are 0.3:100, unit g/ml.
8. according to claim 1 between the sulfanilamide (SN) of the preparation method preparation of Sulfamonomethoxime Sodium described in -7 any claims Sulfamonomethoxine sodium.
CN201710464902.4A 2017-06-19 2017-06-19 A kind of preparation method of Sulfamonomethoxime Sodium and Sulfamonomethoxime Sodium prepared by this method Pending CN109134387A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710464902.4A CN109134387A (en) 2017-06-19 2017-06-19 A kind of preparation method of Sulfamonomethoxime Sodium and Sulfamonomethoxime Sodium prepared by this method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710464902.4A CN109134387A (en) 2017-06-19 2017-06-19 A kind of preparation method of Sulfamonomethoxime Sodium and Sulfamonomethoxime Sodium prepared by this method

Publications (1)

Publication Number Publication Date
CN109134387A true CN109134387A (en) 2019-01-04

Family

ID=64804576

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710464902.4A Pending CN109134387A (en) 2017-06-19 2017-06-19 A kind of preparation method of Sulfamonomethoxime Sodium and Sulfamonomethoxime Sodium prepared by this method

Country Status (1)

Country Link
CN (1) CN109134387A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111471022A (en) * 2020-03-20 2020-07-31 瑞普(天津)生物药业有限公司 Sulfamonomethoxine sodium crystal form and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1082031A (en) * 1993-05-20 1994-02-16 郑州市孝义制药厂 The preparation method of sulfamonomethoxine
WO2011012722A1 (en) * 2009-07-31 2011-02-03 Ascendis Pharma As Prodrugs containing an aromatic amine connected by an amido bond to a linker
CN103319418A (en) * 2013-06-19 2013-09-25 扬州天和药业有限公司 Method for preparing sulfamonomethoxine sodium
CN105294577A (en) * 2015-11-23 2016-02-03 和夏化学(太仓)有限公司 Preparation method for sulfanilamide-6-methoxypyrimidine
CN106565616A (en) * 2016-11-14 2017-04-19 杭州洪晟生物技术股份有限公司 Preparation method of antibacterial veterinary drug sulfamonomethoxine sodium

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1082031A (en) * 1993-05-20 1994-02-16 郑州市孝义制药厂 The preparation method of sulfamonomethoxine
WO2011012722A1 (en) * 2009-07-31 2011-02-03 Ascendis Pharma As Prodrugs containing an aromatic amine connected by an amido bond to a linker
CN103319418A (en) * 2013-06-19 2013-09-25 扬州天和药业有限公司 Method for preparing sulfamonomethoxine sodium
CN105294577A (en) * 2015-11-23 2016-02-03 和夏化学(太仓)有限公司 Preparation method for sulfanilamide-6-methoxypyrimidine
CN106565616A (en) * 2016-11-14 2017-04-19 杭州洪晟生物技术股份有限公司 Preparation method of antibacterial veterinary drug sulfamonomethoxine sodium

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111471022A (en) * 2020-03-20 2020-07-31 瑞普(天津)生物药业有限公司 Sulfamonomethoxine sodium crystal form and preparation method thereof
CN111471022B (en) * 2020-03-20 2024-05-14 瑞普(天津)生物药业有限公司 Sulfamethoxypyrimidine sodium crystal form and preparation method thereof

Similar Documents

Publication Publication Date Title
CN105801645B (en) The method for preparing Suo Feibuwei crystal form 6
CN102491918B (en) Alanyl glutamine compound and preparation method thereof
CN111548310B (en) Levosimendan sodium crystal form and preparation method thereof
CN102993179A (en) Preparation method of high-purity sodium rabeprazole
CN107739396B (en) Crystallization method for improving bulk density and fluidity and preparing non-agglomerated azithromycin
CN104788472B (en) One water Cefazolin sodium spheroidal particle and its crystallization preparation method
CN109134387A (en) A kind of preparation method of Sulfamonomethoxime Sodium and Sulfamonomethoxime Sodium prepared by this method
CN104277053B (en) A kind of preparation method of Cefodizime and its intermediate cefodizime acid
CN102643255A (en) Andrographolide compound
CN105440054B (en) A kind of technique preparing cefathiamidine
US20190225574A1 (en) New crystalline form of gamma-aminobutyric acid and preparation method thereof
EP3502121A1 (en) Polymyxin b sulphate crystal and preparation method therefor
CN108863831A (en) A kind of hydrochloride for injection Propacetamol and preparation method thereof
CN103965101A (en) Preparation method of high-purity milrinone
HU230034B1 (en) Acetyl l-carnitine salt with a dicarboxilic organic acid and process for preparing same
CN104327049B (en) The preparation method of dextral-rabeprazole sodium monohydrate crystals
US3932490A (en) Doxycycline aceturate
KR101673979B1 (en) Compound jk12a and preparation thereof
CN111377840A (en) Preparation method of R- (+) -dihydrolipoic acid
CN109134388A (en) A kind of preparation method of Sulfamonomethoxime Sodium
CN111116568B (en) Preparation method of amorphous canagliflozin
CN108299323A (en) A kind of novel crystal forms of anti-heart failure cocrystalization compound
CN104072362A (en) Synthesis process for antiviral chemical compound protocatechuic acid
CN113149922B (en) Large-scale production method of Sacubitril valsartan sodium crystal form II
CN108329322B (en) Preparation method of vildagliptin cyclic amidine impurity

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190104

RJ01 Rejection of invention patent application after publication